LGVAX
Price
$100.73
Change
+$0.90 (+0.90%)
Updated
Sep 26 closing price
Net Assets
3.9B
RMFCX
Price
$61.27
Change
+$0.38 (+0.62%)
Updated
Sep 26 closing price
Net Assets
111.09B
Interact to see
Advertisement

LGVAX vs RMFCX

Header iconLGVAX vs RMFCX Comparison
Open Charts LGVAX vs RMFCXBanner chart's image
ClearBridge Value A
Price$100.73
Change+$0.90 (+0.90%)
VolumeN/A
Net Assets3.9B
American Funds American Mutual R3
Price$61.27
Change+$0.38 (+0.62%)
VolumeN/A
Net Assets111.09B
LGVAX vs RMFCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LGVAX vs. RMFCX commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGVAX is a Buy and RMFCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 111B vs. LGVAX (3.9B). RMFCX pays higher dividends than LGVAX: RMFCX (1.24) vs LGVAX (0.75). LGVAX was incepted earlier than RMFCX: LGVAX (17 years) vs RMFCX (23 years). LGVAX (1.04) is less costly to investors than RMFCX (0.91). LGVAX is a more actively managed with annual turnover of: 54.00 vs. RMFCX (31.00). RMFCX has a lower initial minimum investment than LGVAX: RMFCX (250) vs LGVAX (1000). RMFCX annual gain was more profitable for investors over the last year : 6.41 vs. LGVAX (-2.76). RMFCX return over 5 years is better than : 63.20 vs. LGVAX (38.09).
LGVAXRMFCXLGVAX / RMFCX
Total Expense Ratio1.010.91111%
Annual Report Gross Expense Ratio1.040.91114%
Fund Existence17 years23 years-
Gain YTD6.70613.24551%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets3.9B111B4%
Annual Yield % from dividends0.751.2461%
Returns for 1 year-2.766.41-43%
Returns for 3 years26.7442.1064%
Returns for 5 years38.0963.2060%
Returns for 10 years83.74103.6281%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTDZX151.862.65
+1.78%
Franklin Biotechnology Discovery Adv
JMVRX38.030.49
+1.31%
JPMorgan Mid Cap Value R5
FSCAX32.650.31
+0.96%
Nuveen Small Cap Value A
PGEMX27.600.09
+0.33%
George Putnam Balanced M
AGLYX14.74N/A
N/A
Ariel Global Institutional